In order to substantiate these findings, we conducted an analysis of the immunohistochemistry of TEDC2 across various tumors within the HPA database, results demonstrated that a noteworthy increase in the expression of the TEDC2 protein within certain tumor samples (Figure 2D). This evidence concerns the gene TEDC2 and neoplasm.